Ortho Regenerative Technologies

Ortho Regenerative Technologies Inc. is an emerging biologics company dedicated to developing novel therapeutic tissue repair technologies to significantly improve the success rates of orthopedic musculoskeletal surgeries.Ortho Regenerative Technologies' proprietary RESTORE technology platform is a biopolymer matrix based on mucoadhesive CHITOSAN, specifically designed to deliver biologics such as Platelet-Rich Plasma (PRP) or Bone Marrow Aspirate Concentrate (BMAC) to enhance and guide the regeneration of various new tissues for the recovery of musculoskeletal disorders.Ortho-R is the company’s leading chitosan-PRP hybrid bioimplant product, formulated and designed to improve the healing rates of tendon, meniscus, and ligament injuries related to occupational and sports activities.Ortho Regenerative Technologies is developing additional formulations for cartilage repair, bone void filling, and osteoarthritis treatment.